Literature DB >> 8627764

Frequent perinatal transmission of feline immunodeficiency virus by chronically infected cats.

L L O'Neil1, M J Burkhard, E A Hoover.   

Abstract

Vertical transmission of feline immunodeficiency virus (FIV) was studied in cats infected with either of two FIV clinical isolates (FIV-B-2542 or FIV-AB-2771) prior to breeding and conception. Queens infected 4 to 30 months (mean = 14 months) prior to conception transmitted FIV to 59 of 83 (71%) kittens; 50.6% were virus positive on the day of birth. To examine potential routes of FIV transmission from mother to offspring, kittens were delivered via either vaginal or cesarean birth and nursed by either their virus-infected natural mothers or uninfected surrogate mothers. Comparison of FIV infection rates at birth with those at 6 months of age in kittens delivered by cesarean and surrogate raised demonstrated that late in utero transmission occurred in approximately 20% of kittens. Comparison of kittens nursed by FIV mothers with those by uninfected surrogate mothers demonstrated a 13.5% increase in infection rate of kittens exposed to milk-borne virus. Isolation of virus from 40% of maternal vaginal wash samples and the slightly greater infection rate in vaginally versus cesarean-delivered surrogate-nursed kittens suggested that intrapartum transmission may occur. In addition, we found that low maternal CD4 count (<200 cells per microl), longer duration of maternal infection (>15 months), and maternal symptoms of clinical immunodeficiency correlated with increased rates of mother-to-kitten FIV transmission, paralleling observations in human immunodeficiency virus-infected women. We conclude that FIV infection provides a model in which to explore aspects of human immunodeficiency virus vertical transmission and intervention difficult to address in human patients.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8627764      PMCID: PMC190147     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  40 in total

1.  Epidemiology of women with AIDS in the United States, 1981 through 1990. A comparison with heterosexual men with AIDS.

Authors:  T V Ellerbrock; T J Bush; M E Chamberland; M J Oxtoby
Journal:  JAMA       Date:  1991-06-12       Impact factor: 56.272

2.  High risk of HIV-1 infection for first-born twins. The International Registry of HIV-exposed Twins.

Authors:  J J Goedert; A M Duliège; C I Amos; S Felton; R J Biggar
Journal:  Lancet       Date:  1991-12-14       Impact factor: 79.321

3.  HIV-1 in trophoblastic and villous Hofbauer cells, and haematological precursors in eight-week fetuses.

Authors:  S H Lewis; C Reynolds-Kohler; H E Fox; J A Nelson
Journal:  Lancet       Date:  1990-03-10       Impact factor: 79.321

4.  Flow cytometric analysis of T-lymphocyte subsets in cats.

Authors:  G A Dean; S L Quackenbush; C D Ackley; M D Cooper; E A Hoover
Journal:  Vet Immunol Immunopathol       Date:  1991-07       Impact factor: 2.046

5.  Progressive immune dysfunction in cats experimentally infected with feline immunodeficiency virus.

Authors:  M Torten; M Franchini; J E Barlough; J W George; E Mozes; H Lutz; N C Pedersen
Journal:  J Virol       Date:  1991-05       Impact factor: 5.103

6.  Prevalence of HIV infection in childbearing women in the United States. Surveillance using newborn blood samples.

Authors:  M Gwinn; M Pappaioanou; J R George; W H Hannon; S C Wasser; M A Redus; R Hoff; G F Grady; A Willoughby; A C Novello
Journal:  JAMA       Date:  1991-04-03       Impact factor: 56.272

7.  Development of monoclonal antibodies and capture immunoassays for feline immunodeficiency virus.

Authors:  M J Dreitz; S W Dow; S A Fiscus; E A Hoover
Journal:  Am J Vet Res       Date:  1995-06       Impact factor: 1.156

8.  Nucleotide sequence and genomic organization of feline immunodeficiency virus.

Authors:  R L Talbott; E E Sparger; K M Lovelace; W M Fitch; N C Pedersen; P A Luciw; J H Elder
Journal:  Proc Natl Acad Sci U S A       Date:  1989-08       Impact factor: 11.205

9.  Immunologic abnormalities in pathogen-free cats experimentally infected with feline immunodeficiency virus.

Authors:  C D Ackley; J K Yamamoto; N Levy; N C Pedersen; M D Cooper
Journal:  J Virol       Date:  1990-11       Impact factor: 5.103

10.  Postnatal transmission of human immunodeficiency virus type 1 from mother to infant. A prospective cohort study in Kigali, Rwanda.

Authors:  P Van de Perre; A Simonon; P Msellati; D G Hitimana; D Vaira; A Bazubagira; C Van Goethem; A M Stevens; E Karita; D Sondag-Thull
Journal:  N Engl J Med       Date:  1991-08-29       Impact factor: 91.245

View more
  31 in total

1.  Epidemiology, genetic diversity, and evolution of endemic feline immunodeficiency virus in a population of wild cougars.

Authors:  Roman Biek; Allen G Rodrigo; David Holley; Alexei Drummond; Charles R Anderson; Howard A Ross; Mary Poss
Journal:  J Virol       Date:  2003-09       Impact factor: 5.103

2.  Seroprevalence of feline immunodeficiency virus (FIV) and feline leukemia virus (FeLV) in shelter cats on the island of Newfoundland, Canada.

Authors:  Hannah J Munro; Lesley Berghuis; Andrew S Lang; Laura Rogers; Hugh Whitney
Journal:  Can J Vet Res       Date:  2014-04       Impact factor: 1.310

3.  Expression of regulatory T cell (Treg) activation markers in endometrial tissues from early and late pregnancy in the feline immunodeficiency virus (FIV)-infected cat.

Authors:  N N Lockett; V L Scott; C E Boudreaux; B T Clay; S B Pruett; P L Ryan; K S Coats
Journal:  Placenta       Date:  2010-08-02       Impact factor: 3.481

Review 4.  Feline immunodeficiency virus model for designing HIV/AIDS vaccines.

Authors:  Janet K Yamamoto; Missa P Sanou; Jeffrey R Abbott; James K Coleman
Journal:  Curr HIV Res       Date:  2010-01       Impact factor: 1.581

Review 5.  Feline immunodeficiency virus (FIV) as a model for study of lentivirus infections: parallels with HIV.

Authors:  John H Elder; Ying-Chuan Lin; Elizabeth Fink; Chris K Grant
Journal:  Curr HIV Res       Date:  2010-01       Impact factor: 1.581

6.  Improved health and survival of FIV-infected cats is associated with the presence of autoantibodies to the primary receptor, CD134.

Authors:  Chris K Grant; Elizabeth A Fink; Magnus Sundstrom; Bruce E Torbett; John H Elder
Journal:  Proc Natl Acad Sci U S A       Date:  2009-11-09       Impact factor: 11.205

Review 7.  Molecular mechanisms of FIV infection.

Authors:  John H Elder; Magnus Sundstrom; Sohela de Rozieres; Aymeric de Parseval; Chris K Grant; Ying-Chuan Lin
Journal:  Vet Immunol Immunopathol       Date:  2008-01-19       Impact factor: 2.046

8.  Prior mucosal exposure to heterologous cells alters the pathogenesis of cell-associated mucosal feline immunodeficiency virus challenge.

Authors:  Surender B Kumar; Sarah Leavell; Kyle Porter; Barnabe D Assogba; Mary J Burkhard
Journal:  Retrovirology       Date:  2010-05-28       Impact factor: 4.602

9.  Expression of CD134 and CXCR4 mRNA in term placentas from FIV-infected and control cats.

Authors:  Veronica L Scott; Shane C Burgess; Leslie A Shack; Nikki N Lockett; Karen S Coats
Journal:  Vet Immunol Immunopathol       Date:  2008-01-19       Impact factor: 2.046

Review 10.  Immunopathogenesis of feline immunodeficiency virus infection in the fetal and neonatal cat.

Authors:  Holly M Kolenda-Roberts; Leah A Kuhnt; Ryan N Jennings; Ayalew Mergia; Nazareth Gengozian; Calvin M Johnson
Journal:  Front Biosci       Date:  2007-05-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.